$126 Million is the total value of 72 Investment Holdings, LLC's 5 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | PROMETHEUS BIOSCIENCES INC | $109,052,000 | +109.0% | 1,848,024 | 0.0% | 86.39% | +7.2% | |
| ENTRADA THERAPEUTICS INC | $8,022,000 | +29.4% | 509,023 | 0.0% | 6.36% | -33.7% | ||
| CARIBOU BIOSCIENCES INC | $5,001,000 | +94.3% | 474,067 | 0.0% | 3.96% | -0.4% | ||
| PRAX | PRAXIS PRECISION MEDICINES I | $2,245,000 | -7.3% | 988,995 | 0.0% | 1.78% | -52.5% | |
| OMEGA THERAPEUTICS INC | $1,913,000 | +42.7% | 352,941 | 0.0% | 1.52% | -26.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 12 | Q3 2023 | 49.0% |
| PROMETHEUS BIOSCIENCES INC | 9 | Q1 2023 | 93.9% |
| CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 15.7% |
| OMEGA THERAPEUTICS INC | 9 | Q3 2023 | 15.4% |
| ENTRADA THERAPTEUTICS INC | 8 | Q3 2023 | 60.0% |
| WEWORK INC | 2 | Q1 2022 | 0.2% |
| PALANTIR TECHNOLOGIES INC | 1 | Q4 2020 | 92.7% |
| TURNSTONE BIOLOGICS CORP | 1 | Q3 2023 | 14.5% |
View 72 Investment Holdings, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View 72 Investment Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.